secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTERPACE BIOSCIENCES, INC. (IDXG)
CIK:        0001054102
Form:       8-K
Filed at:   2023-12-12T23:59:59+00:00
Accession:  0001493152-23-044550
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Robert Gorman resigns from Interpace board, cites compensation dispute
-------------------------------------------------------------------------------

- Robert Gorman resigned as director and Chairman effective December 7, 2023.
- Resignation not due to any disagreement with company's operations, policies, or practices.
- Gorman disagreed with timing of proposed change from Executive Chairman to Chairman and reduction in compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1054102/000149315223044550/0001493152-23-044550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1054102/000149315223044550/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-044550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer